CSL Vifor
CSL is a global biotechnology company dedicated to delivering innovative therapies and solutions for patients with rare and serious diseases, vaccines, and other health needs. With a focus on research, development, and sustainability, CSL aims to improve life worldwide through its diverse portfolio of products and services. The company emphasizes inclusion, community impact, employee well-being, and long-term partnerships as core parts of its mission.
Industries
Nr. of Employees
Very Large (1000+)
CSL Vifor
1020 First Avenue, P.O. Box 61501, King of Prussia, PA 19406-1310, USA
Products
Plasma-derived therapeutic proteins
Plasma-derived therapeutic proteins for treatment of bleeding disorders, immunodeficiencies, hereditary angioedema and other rare or serious diseases.
Recombinant protein therapies
Therapeutic proteins produced via recombinant expression platforms as alternatives to plasma-derived products.
Influenza vaccines and specialty biologics
Influenza vaccines produced using egg- and cell-based platforms and adjuvant formulations, plus other specialty biologic products for public health use.
Human serum albumin and plasma-derived materials for manufacturing
Medical-grade human serum albumin and other plasma-derived materials supplied for excipient, formulation and device manufacturing applications.
Plasma-derived therapeutic proteins
Plasma-derived therapeutic proteins for treatment of bleeding disorders, immunodeficiencies, hereditary angioedema and other rare or serious diseases.
Recombinant protein therapies
Therapeutic proteins produced via recombinant expression platforms as alternatives to plasma-derived products.
Influenza vaccines and specialty biologics
Influenza vaccines produced using egg- and cell-based platforms and adjuvant formulations, plus other specialty biologic products for public health use.
Human serum albumin and plasma-derived materials for manufacturing
Medical-grade human serum albumin and other plasma-derived materials supplied for excipient, formulation and device manufacturing applications.
Services
Provision of human serum albumin and other plasma-derived proteins for use as excipients, culture media components, device coatings and other manufacturing inputs, with accompanying quality and regulatory support.
Assistance for partners covering regulatory strategy, coordination for market authorizations and compliance conditions for co-developed or supplied materials.
Management and information for clinical studies and ongoing clinical trial programs, including investigator site interactions.
Regional medical information contacts providing product, safety and prescribing information for healthcare professionals.
Channels and processes for reporting adverse events and product complaints with regional contact points to ensure compliance with safety reporting and complaint investigation obligations.
Operation of plasma donor centers and donor inquiry/feedback channels to support raw material supply for biologics manufacturing.
Provision of human serum albumin and other plasma-derived proteins for use as excipients, culture media components, device coatings and other manufacturing inputs, with accompanying quality and regulatory support.
Assistance for partners covering regulatory strategy, coordination for market authorizations and compliance conditions for co-developed or supplied materials.
Management and information for clinical studies and ongoing clinical trial programs, including investigator site interactions.
Regional medical information contacts providing product, safety and prescribing information for healthcare professionals.
Channels and processes for reporting adverse events and product complaints with regional contact points to ensure compliance with safety reporting and complaint investigation obligations.
Operation of plasma donor centers and donor inquiry/feedback channels to support raw material supply for biologics manufacturing.
Expertise Areas
- Plasma-derived therapeutics
- Recombinant protein development
- Vaccine development and manufacturing
- Cell and gene therapy research
Key Technologies
- Plasma fractionation and plasma protein processing
- Recombinant protein expression platforms
- Egg-based vaccine production
- Cell-based vaccine production